möglich sobald bei der ZB eingereicht worden ist.
Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine.
Nat. Rev. Gastroenterol. Hepatol. 22, 226–227 (2025)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous disease regarding its pathophysiology and clinical outcomes. Two novel studies suggest that different clusters of people with MASLD exist, explaining part of this heterogeneity. These findings and future research applying data dimensionality reduction approaches might be beneficial for implementing precision medicine in MASLD.
Altmetric
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Sonstiges: Nachrichtenmeldung
Sprache
englisch
Veröffentlichungsjahr
2025
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
1759-5045
e-ISSN
1759-5053
Zeitschrift
Nature Reviews - Gastroenterology & Hepatology
Quellenangaben
Band: 22,
Seiten: 226–227
Verlag
Nature Publishing Group
Verlagsort
Heidelberger Platz 3, Berlin, 14197, Germany
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502400-001
Förderungen
European Innovative Medicines Initiative SOPHIA
German Center of Diabetes Research (DZD)
German Federal Ministry of Education and Research (BMBF)
German Center of Diabetes Research (DZD)
German Federal Ministry of Education and Research (BMBF)
WOS ID
001433269600001
Scopus ID
86000017484
PubMed ID
40011752
Erfassungsdatum
2025-04-30